How do Doximity, Inc. and TRIMAS CORP compare by revenue?

Doximity, Inc. reported revenue of $185.1M in Q3 FY2026, while TRIMAS CORP reported $256.5M in Q1 FY2026. TRIMAS CORP is 1.4× larger by last-quarter revenue.

Which is growing revenue faster, Doximity, Inc. or TRIMAS CORP?

Doximity, Inc.'s latest revenue grew 9.8% year-over-year, versus 3.8% for TRIMAS CORP. Doximity, Inc. is growing faster on a YoY basis.

Which has a higher gross margin, Doximity, Inc. or TRIMAS CORP?

Doximity, Inc.'s gross margin is 89.9% vs TRIMAS CORP's 12.8%. Doximity, Inc. converts more of each revenue dollar into gross profit.

Which has a higher net margin, Doximity, Inc. or TRIMAS CORP?

Doximity, Inc.'s net margin is 33.3% vs TRIMAS CORP's 31.9%. Doximity, Inc. has the higher bottom-line margin.

What is the 2-year revenue CAGR for Doximity, Inc. vs TRIMAS CORP?

Over the trailing 8 quarters, Doximity, Inc. compounded revenue at roughly 25.2% per year, versus 3.3% for TRIMAS CORP. Doximity, Inc. has the faster medium-term growth trajectory.

Where does this DOCS vs TRS data come from?

All figures are parsed directly from SEC EDGAR 10-Q / 10-K / 20-F / 6-K filings (for US-listed issuers) or EDINET filings (for Japanese issuers), then normalised into a common schema. Numbers update automatically as new filings are released.

vs

Side-by-side financial comparison of Doximity, Inc. (DOCS) and TRIMAS CORP (TRS). Click either name above to swap in a different company.

TRIMAS CORP is the larger business by last-quarter revenue ($256.5M vs $185.1M, roughly 1.4× Doximity, Inc.). Doximity, Inc. runs the higher net margin — 33.3% vs 31.9%, a 1.4% gap on every dollar of revenue. On growth, Doximity, Inc. posted the faster year-over-year revenue change (9.8% vs 3.8%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs 3.3%).

Doximity, Inc.DOCSEarnings & Financial Report

NYSE · Information Technology · Services-Computer Programming Services

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

TRIMAS CORPTRSEarnings & Financial Report

Nasdaq · Industrials · Metal Forgings & Stampings

Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.

DOCS vs TRS — Head-to-Head

Bigger by revenue

TRS

1.4× larger

$256.5M

$185.1M

Growing faster (revenue YoY)

DOCS

+5.9% gap

9.8%

3.8%

Higher net margin

DOCS

1.4% more per $

33.3%

31.9%

Faster 2-yr revenue CAGR

DOCS

Annualised

25.2%

3.3%

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric	DOCS	TRS
Revenue	$185.1M	$256.5M
Net Profit	$61.6M	$81.7M
Gross Margin	89.9%	12.8%
Operating Margin	38.9%	5.7%
Net Margin	33.3%	31.9%
Revenue YoY	9.8%	3.8%
Net Profit YoY	-18.1%	236.9%
EPS (diluted)	$0.31	$2.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue

DOCS

TRS

Q1 26	—	$256.5M
Q4 25	$185.1M	$-140.0M
Q3 25	$168.5M	$269.3M
Q2 25	$145.9M	$274.8M
Q1 25	$138.3M	$241.7M
Q4 24	$168.6M	$-66.2M
Q3 24	$136.8M	$229.4M
Q2 24	$126.7M	$240.5M

Net Profit

DOCS

TRS

Q1 26	—	$81.7M
Q4 25	$61.6M	$81.7M
Q3 25	$62.1M	$9.3M
Q2 25	$53.3M	$16.7M
Q1 25	$62.5M	$12.4M
Q4 24	$75.2M	$5.6M
Q3 24	$44.2M	$2.5M
Q2 24	$41.4M	$10.9M

Gross Margin

DOCS

TRS

Q1 26	—	12.8%
Q4 25	89.9%	—
Q3 25	90.3%	12.8%
Q2 25	89.2%	13.8%
Q1 25	89.5%	13.6%
Q4 24	91.6%	—
Q3 24	90.0%	15.4%
Q2 24	89.3%	14.4%

Operating Margin

DOCS

TRS

Q1 26	—	5.7%
Q4 25	38.9%	—
Q3 25	37.8%	6.2%
Q2 25	37.4%	9.9%
Q1 25	35.2%	9.0%
Q4 24	47.4%	—
Q3 24	38.8%	3.6%
Q2 24	36.4%	7.4%

Net Margin

DOCS

TRS

Q1 26	—	31.9%
Q4 25	33.3%	-58.4%
Q3 25	36.8%	3.5%
Q2 25	36.5%	6.1%
Q1 25	45.2%	5.1%
Q4 24	44.6%	-8.5%
Q3 24	32.3%	1.1%
Q2 24	32.7%	4.5%

EPS (diluted)

DOCS

TRS

Q1 26	—	$2.03
Q4 25	$0.31	$2.01
Q3 25	$0.31	$0.23
Q2 25	$0.27	$0.41
Q1 25	$0.31	$0.30
Q4 24	$0.37	$0.14
Q3 24	$0.22	$0.06
Q2 24	$0.21	$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric	DOCS	TRS
Cash + ST InvestmentsLiquidity on hand	$64.8M	$30.0M
Total DebtLower is stronger	—	—
Stockholders' EquityBook value	$979.3M	$705.6M
Total Assets	$1.2B	$1.5B
Debt / EquityLower = less leverage	—	—

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments

DOCS

TRS

Q1 26	—	$30.0M
Q4 25	$64.8M	$30.0M
Q3 25	$169.2M	$33.6M
Q2 25	$137.3M	$30.3M
Q1 25	$209.6M	$32.7M
Q4 24	$165.3M	$23.1M
Q3 24	$184.2M	$26.9M
Q2 24	$111.4M	$35.0M

Total Debt

DOCS

TRS

Q1 26	—	—
Q4 25	—	$469.2M
Q3 25	—	$407.1M
Q2 25	—	$424.5M
Q1 25	—	$434.2M
Q4 24	—	$398.1M
Q3 24	—	$409.9M
Q2 24	—	$427.4M

Stockholders' Equity

DOCS

TRS

Q1 26	—	$705.6M
Q4 25	$979.3M	$705.6M
Q3 25	$1.1B	$725.0M
Q2 25	$1.0B	$715.3M
Q1 25	$1.1B	$686.6M
Q4 24	$1.0B	$667.3M
Q3 24	$961.2M	$682.8M
Q2 24	$913.6M	$675.9M

Total Assets

DOCS

TRS

Q1 26	—	$1.5B
Q4 25	$1.2B	$1.5B
Q3 25	$1.3B	$1.4B
Q2 25	$1.2B	$1.4B
Q1 25	$1.3B	$1.4B
Q4 24	$1.2B	$1.3B
Q3 24	$1.1B	$1.4B
Q2 24	$1.1B	$1.4B

Debt / Equity

DOCS

TRS

Q1 26	—	—
Q4 25	—	0.66×
Q3 25	—	0.56×
Q2 25	—	0.59×
Q1 25	—	0.63×
Q4 24	—	0.60×
Q3 24	—	0.60×
Q2 24	—	0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric	DOCS	TRS
Operating Cash FlowLast quarter	$60.9M	$117.5M
Free Cash FlowOCF − Capex	—	$36.8M
FCF MarginFCF / Revenue	—	14.4%
Capex IntensityCapex / Revenue	—	18.9%
Cash ConversionOCF / Net Profit	0.99×	1.44×
TTM Free Cash FlowTrailing 4 quarters	—	$109.7M